Welcome to AMR at the Nexus of Science, Society, Commercialization, and Policy
Expandable List
8:00 – 8:45 a.m.
Breakfast
8:45 – 9:15 a.m.
Welcome, Land acknowledgement & Opening Remarks
Gerry Wright, Global Nexus Lead
David Farrar, President and Vice-Chancellor
Karen Mossman, Vice-President, Research
9:15 – 9:45 a.m.
Dr. Ayush Kumar
“Prevalence of antimicrobial resistance in the First Nation communities in Canada: Role of source and drinking water”
9:45 – 10:15 a.m.
Dr. Christine Årdal
“Unraveling the complexities of AMR access”
10:15 – 10:30 a.m.
Break
10:30 – 11:00 a.m.
Dr. Kevin Outterson
“A vision for the Independent Panel on Evidence For Action on AMR”
11:00 – 11:30 a.m.
Dr. Muhammad Zaman
“Analyzing the AMR drivers in refugee camps and informal settlements: From environmental degradation to drug quality”
11:30 a.m. – 12:30 p.m.
Panel discussion and Q&A
12:30 – 1:30 p.m.
Lunch
1:30 – 2:15 p.m.
Breakout sessions (Part 1)
Focus: Research questions and opportunities within each of the breakout session’s theme
2:15 – 2:30 p.m.
Break
2:30 – 3:00 p.m.
Plenary discussion from Breakout session 1
3:00 – 3:45 p.m.
Breakout sessions (Part 2)
Focus: What is needed to advance interdisciplinary AMR research at McMaster?
3:45 – 4:15 p.m.
Closing session/recap
4:15 – 4:30 p.m.
Closing remarks
Eric Brown, AMR Taskforce Co-Chair
Marie Elliot, AMR Taskforce Co-chair
Dr. Ayush Kumar
Ayush Kumar is a Professor in the Department of Microbiology at the University of Manitoba. He is currently the Associate Dean, Strategic Initiatives in the Faculty of Science. Kumar completed his BSc (Microbiology and Biochemistry) and MSc (Microbiology) from Dr. R.M.L. Awadh University, Faizabad, India. His PhD work was carried out in the laboratory of Dr. Elizabeth Worobec, Department of Microbiology, University of Manitoba. Kumar received his post-doctoral training in the laboratory of Dr. Herbert Schweizer, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft. Collins, CO. He joined the Faculty of Health Sciences at the University of Ontario Institute of Technology (now Ontario Tech University) as an Assistant Professor in 2007. Kumar relocated his laboratory to the University of Manitoba in 2013. Kumar was the President of the Canadian Society of Microbiologists (CSM) in 2020-2021 and the inaugural Chair of the CSM Equity, Diversity, Inclusion subcommittee.
Dr. Christine Årdal
Christine Årdal MBA PhD has worked for over 20 years on access to medicines through different sectors, including research institutes, governmental development assistance, pharmacy, national health service and insurance. At the Norwegian Institute of Public Health, her research focuses on the policy aspects of antimicrobial access and innovation. Årdal was a co-lead in the DRIVE-AB research project which aimed to transform the way policymakers stimulate innovation, the sustainable use, and the equitable availability of novel antibiotics to meet unmet public health needs. She is currently the co-lead of the research and innovation work package for the European Union’s Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI), which aims to detail European strategies to implement mechanisms to increase antibiotic and alternative therapeutic innovation. Previously she was a member of the World Health Organization expert review panel for the overall programme review of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. She led the Norwegian Agency for Development Cooperation’s (Norad) efforts within the UN Commission on Life-Saving Commodities for Women and Children.
Dr. Kevin Outterson
Kevin Outterson is a global thought leader on business models for antibiotic development and use. He is Professor of Law and N. Neil Pike Scholar of Health and Disability Law at Boston University School of Law, where he leads multi-disciplinary teams to solve global health issues. Outterson is the Executive Director and Principal Investigator of CARB-X and a partner in DRIVE-AB.
Dr. Muhammad Zaman
Muhammad Hamid Zaman is the Howard Hughes Medical Institute Professor of Biomedical Engineering and Inaugural Director of the Center for Forced Displacement at Boston University. A major research theme in his lab focuses on analyzing how poor-quality medicines drive antimicrobial resistance in resource-limited settings. His work also focuses on developing models and technological and policy solutions to improve access to quality care for drug- resistance infections (quality medicines, diagnostic tests, etc) in low-income settings, including in refugee settlements. In addition to peer-reviewed research articles, he is the author of two books for broad audiences. His first book, Bitter Pills (Oxford University Press, 2018), looks at the global challenge of substandard and counterfeit drugs. His second book, Biography of Resistance (Harper Collins, 2020), is focused on global antimicrobial resistance. It is a story of science and evolution that looks to history, culture, attitudes, our own individual choices, and collective human behavior in creating one of the biggest public health challenges of our time. Zaman has written extensively on innovation, and refugee and global health in newspapers around the world. His newspaper columns have appeared in more than 30 countries and have been translated into eight languages. He has won numerous awards for his teaching and research, the most recent being Guggenheim Fellowship (2020) for his work on antibiotic resistance in refugee camps.
-
MDCL-2218 Society A
-
MDCL-2244 Society B
-
MDCL-2233 Commercialization A
-
MDCL-2230 Commercialization B
-
MDCL-2242 Policy A
- MDCL-3412 Policy B
-
MDCL-3016 Science A
-
MDCL-3017 Science B